55 results
8-K
EX-99.1
fx21u3gduu9qs3jtv625
29 Mar 24
Results of Operations and Financial Condition
8:35am
8-K
EX-99.1
1moaoos4zjaxdwjze817
9 Jan 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
8:11am
8-K
EX-99.1
y9diq6u9zb0
9 Nov 23
Results of Operations and Financial Condition
4:41pm
8-K/A
EX-99.1
knq3 x18d4
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K/A
EX-99.3
fw9ms01b7
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K/A
EX-99.2
i43dc0 5n
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K
EX-99.1
c27hyloq 8put15
11 Aug 23
Elicio Therapeutics Reports Second Quarter 2023 Financial Results and Provides
11:42am
8-K
EX-99.3
7o55gc0
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.4
azvvcz423u8qhgq0zl86
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-10.2
6b2kv qosf8
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.5
xwnrju37mpoekhku0
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
45dxs5ddt3uyox5
28 Apr 23
Prospectus supplement
4:07pm